AmniSure Test for ROM (Rupture of Fetal Membranes) Featured in Contemporary OB/GYN Magazine
AmniSure, a product available from Sepal Reproductive Devices, has recently been featured in a variety of medical magazines including a recent piece in Contemporary OB/GYN. This article discusses the new AmniSure technology in depth and highlights its clinical benefits.
Sudbury, MA, November 30, 2005 --(PR.com)-- AmniSure, a product available from Sepal Reproductive Devices, has recently been featured in a variety of medical magazines including a recent piece in Contemporary OB/GYN. This article discusses the new AmniSure technology in depth and highlights its clinical benefits.
Several technologies are discussed in the November 15th issue of Contemporary OB/GYN, including AmniSure, a biochemical test for the detection of preterm premature rupture of fetal membranes (pPROM), improved ultrasound imaging, non-invasive prenatal genetic screening and an overall increase in the speed of diagnosing intra-amniotic infection.
Attending to one’s reproductive health during a pregnancy is a great responsibility, requiring careful consideration of new innovations and practices. The authors state that “reproductive health can be somewhat of a “data-free zone” in which professionals are required to make managerial decisions and recommendations without the benefit of solid data to back up their findings.” As a result, OB/GYN’s continue to debate even the most basic fundamental questions. The authors predict that this new technology will “improve the ability of obstetric care providers” to achieve the best possible outcomes as they “find their way into clinical practice within the very near future.”
http://www.contemporaryobgyn.net/obgyn/article/articleDetail.jsp?id=181112&&pageID=2
Sepal Reproductive Devices is a distinguished leader in the design, discovery and marketing of innovative medical products. Sepal supplies a full range of devices for assisted reproductive technologies as well as the latest advances in diagnostic testing devices that promote the health and well-being of women. Sepal’s range of testing kits includes ovulation and menopause detection kits, and a rapid diagnostic test that detects rupture of (fetal) membranes (ROM). Sepal is a privately held company based in Sudbury, Massachusetts. Since its inception in 2000, Sepal has serviced thousands of healthcare professionals, infertility centers and hospitals around the world. For additional information please visit: http://www.sepalreprodevices.com
20051130SS01
###
Several technologies are discussed in the November 15th issue of Contemporary OB/GYN, including AmniSure, a biochemical test for the detection of preterm premature rupture of fetal membranes (pPROM), improved ultrasound imaging, non-invasive prenatal genetic screening and an overall increase in the speed of diagnosing intra-amniotic infection.
Attending to one’s reproductive health during a pregnancy is a great responsibility, requiring careful consideration of new innovations and practices. The authors state that “reproductive health can be somewhat of a “data-free zone” in which professionals are required to make managerial decisions and recommendations without the benefit of solid data to back up their findings.” As a result, OB/GYN’s continue to debate even the most basic fundamental questions. The authors predict that this new technology will “improve the ability of obstetric care providers” to achieve the best possible outcomes as they “find their way into clinical practice within the very near future.”
http://www.contemporaryobgyn.net/obgyn/article/articleDetail.jsp?id=181112&&pageID=2
Sepal Reproductive Devices is a distinguished leader in the design, discovery and marketing of innovative medical products. Sepal supplies a full range of devices for assisted reproductive technologies as well as the latest advances in diagnostic testing devices that promote the health and well-being of women. Sepal’s range of testing kits includes ovulation and menopause detection kits, and a rapid diagnostic test that detects rupture of (fetal) membranes (ROM). Sepal is a privately held company based in Sudbury, Massachusetts. Since its inception in 2000, Sepal has serviced thousands of healthcare professionals, infertility centers and hospitals around the world. For additional information please visit: http://www.sepalreprodevices.com
20051130SS01
###
Contact
Sepal Reproductive Devices
Doug Nyren
877.546.4223
www.sepalreprodevices.com
Doug Nyren
877.546.4223
www.sepalreprodevices.com
Contact